TechNet-21 - Forum

This forum provides a place for members to ask questions, share experiences, coordinate activities, and discuss recent developments in immunization.
  1. Géraldine Nemrod
  2. Programme management
  3. Friday, 12 March 2021

The Access to COVID-19 Tools (ACT) Accelerator’s Country Readiness and Delivery (CRD) workstream, Project ECHO, Boost, TechNet-21, and the COVID-19 Vaccine Equity Project invite you to join a series of video-conference-based capacity building webinars.

Topic: Understanding COVID-19 vaccines - safety and efficacy

When: 16 March session (12-1PM CET)

Registration: https://echo.zoom.us/webinar/register/WN_81Wgk82kRcmmMVJ43SNOuA

TechNet-21 also manages two Telegram channels supporting regions, countries, and partners in preparing for COVID-19 vaccine introduction. In these two spaces - one anglophone and one francophone - you will be able to share your experiences, discuss key questions, and connect with experts from around the world. We'll also share new information and global guidance as it becomes available. Join us today:

COVID-19 Vaccine Introduction – TechNet-21 (English)

Introduction des vaccins contre la Covid-19 – TechNet-21 (Français)

Géraldine Nemrod Accepted Answer
Admin

Dear colleagues,

The questions that could not be answered during the webinar session have been compiled into the following Q&A document:

https://www.technet-21.org/en/library/main/6933-q&a-for-session-#06:-understanding-covid-19-vaccines---safety-and-efficacy

These are the questions that have been answered:

  • How is the WHO planning to convince countries to keep using AstraZeneca given the negative side effects that have occurred?
  • A man and his wife took the AstraZeneca vaccine on 13th of February and on 17th the man collapsed and died without showing any sign of ill health. Can we say the vaccine is the cause of death?
  • I know it is better to have all types of emergency medications available for AEFI kit. However, keeping in mind the poor resource settings, which group of medications you would recommend?
  • What is the procedure to verify that the vaccine is in good condition?
  • What will be the available test of choice to measure protective antibodies after vaccination?
  • COVID-19 vaccines show different results in different environmental condition, do you think environmental condition influence the effectiveness of vaccines?

 

You can now find all the resources for all the COVID-19 Vaccine Introduction webinar sessions here: https://www.technet-21.org/en/topics/covid-19-vaccine

  1. more than a month ago
  2. Programme management
  3. # 1
Géraldine Nemrod Accepted Answer
Admin

Dear colleagues,

The recording of the webinar on Understanding COVID-19 vaccines - safety and efficacy is now available in three languages here:

https://youtu.be/QeVOsOghrIA (English)

https://youtu.be/--0PkkOvA-M (Spanish)

https://youtu.be/A24ksHUWpVg (French)

  1. more than a month ago
  2. Programme management
  3. # 2


There are no replies made for this post yet.
Be one of the first to reply to this post!